Stockscreener 앱 받기
0.38
1.58%
-0.0061
Cosmos Health Inc 주식(COSM)의 최신 뉴스
Cosmos Health's Brands Reach More Than 40 Countries Across Europe, the Middle East, North America and Asia, Addressing Global Markets Estimated at Approximately $946 Billion - Morningstar
Cosmos Health Inc. (COSM) Stock Price, News, Quote & History - Yahoo! Finance Canada
Price to sales ratio of Cosmos Health Inc – HAN:V67A - TradingView
Cosmos Health CosmoFarm Q2FY26 Results: Revenue tops $15M, hits $60M run rate - scanx.trade
COSM Continues to Grow Business - Yahoo Finance
COSM Forecast — Price Target — Prediction for 2027 - TradingView
Cosmos Health's CosmoFarm Reaches Record Annualized Revenue Above $60 Million, Up 4.3x Under Cosmos Health Ownership, as Robotics and AI Build Capacity to Support Over $100 Million in Annualized Revenue - USA Today
Cosmos Health’s CosmoFarm unit reaches $15M quarterly revenue - Investing.com
Cosmos Health’s CosmoFarm unit reaches $15M quarterly revenue By Investing.com - Investing.com South Africa
Robots and AI could let Cosmos Health's pharmacy distributor handle over $100 million in annual sales - Stock Titan
CosmoFarm | A Cosmos Health Company - YouTube
Cosmos Health Subsidiary Cana Laboratories Secures $20M Contract Manufacturing Pipeline (COSM) - GuruFocus
Cosmos Health’s Cana unit surpasses $20M CMO pipeline - Investing.com
Cosmos Health's Contract Manufacturing Division Surpasses $20 Million in Implied Revenue and $18 Million in Implied Gross Profit Across Its Record 32.7 Million-Unit Production Pipeline - Corsicana Daily Sun
Cosmos Health Inc. (COSM) CMO Pipeline Implies $20M Revenue, $18M Gross Profit - TradingView
Why Did SOC, HTZ, COSM Stocks Tumble To 52-Week Lows? - Stocktwits
Cosmos Health stock gains 14.79 percent after record revenue - AD HOC NEWS
Cosmos Health stock trades at USD 0.44 as filings remain central - AD HOC NEWS
Cosmos Health Adds 5.2 Million Units in New Five-Year Agreements with Target Pharma; Orderbook Surges Past 32.7 Million Units, Up 31% Since June - ACCESS Newswire
Cosmos Health stock moves on CCX0722 IP tokenization plan - AD HOC NEWS
Cosmos Health Inc (COSM) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey
Cosmos Health Reports Q1 2026 Results: Revenue Up 31% to $17.9M, New Q1 Record; Total Liabilities Reduced by $4.5M; Stockholders' Equity Up 7.6%; Cash of $2.2M; Record Momentum Continues into Q2 with U.S. Expansion Underway - Newswire.com
Cosmos Health Moves to Tokenize CCX0722 Intellectual Property in Innovative Non-Dilutive Structure, Eyes $562 Billion Weight-Management Market - New Castle News
Cosmos Health subsidiary secures 5.2M unit manufacturing deal - Investing.com
Cosmos Health subsidiary secures 5.2M unit manufacturing deal By Investing.com - Investing.com India
Cosmos Health Adds 5.2 Million Units in New Five-Year Agreements with Target Pharma - FinancialContent
Cosmos Health engages Prime Ledger for tokenized IP financing - Investing.com
Cosmos Health engages Prime Ledger for tokenized IP financing By Investing.com - Investing.com India
A weight-management capsule’s gel expands more than 100-fold. Cosmos Health proposes funding it without new shares. - Stock Titan
Cosmos Health subsidiary secures 5-year manufacturing deal By Investing.com - Investing.com South Africa
Cosmos Health Secures Additional 2.5 Mln Units Under New Five-Year Contract Manufacturing Deal With Viofar - TradingView
COSM Looks 10.4% Undervalued on GF Value™ Amid Contract Manufact - GuruFocus
Cosmos Health Unit Enters 5-Year Contract Manufacturing Deal With Viofar Over Cardiovascular Medicine - Bitget
Cosmos Health subsidiary secures 5-year manufacturing deal - Investing.com
Cosmos Health Secures Additional 2.5 Million Units Under New Five-Year Contract Manufacturing Agreement with Viofar; Total Orderbook Surpasses 27.5 Million Units - ACCESS Newswire
Cosmos Health Launches C-ScrubVet in the UK, Advancing into the $69 Billion Global Animal Health Market - webull.com
Cosmos Health receives first orders for veterinary product line By Investing.com - Investing.com Nigeria
COSM Looks 8.2% Undervalued on GF Value™ Amid Challenging Fundam - GuruFocus
Cosmos Health receives first orders for veterinary product line - Investing.com
Cosmos Health buyback reaches 5.11 million shares under $5 million program - scanx.trade
Cosmos Health reports record revenue, retires $8M debt early By Investing.com - Investing.com Australia
Cosmos Health: A Company Transformed — 2026 Y - Moomoo
Cosmos Health Reaffirms 2029 Guidance - TradingView
Cosmos Health Q2FY26 Results: Revenue up 28.8% to $18.99M - scanx.trade
Cosmos Health reports record revenue, retires $8M debt early - Investing.com
Cosmos Health Inc. - Via Ritzau
Cosmos Health Reports Record H1 2026 Revenue, Strengthened Balance Sheet, and Major Global Expansion Milestones - Quiver Quantitative
Cosmos Health Strengthens Balance Sheet and Streamlines Capital Structure, Retires $8M ATW Convertible Note One Year Ahead of Maturity, Eliminating Further Dilution from Conversions - marketscreener.com
Cosmos Health stock rises after $8 million note retirement - AD HOC NEWS
Cosmos Health retires $8M convertible note early By Investing.com - Investing.com UK
Cosmos Health Strengthens Balance Sheet and Streamlines Capital Structure; Retires $8M ATW Convertible Note One Year Ahead of Maturity, Eliminating Further Dilution From Conversions - kommunikasjon.ntb.no
Cosmos Health Retires $8 Million Convertible Note Early, Simplifies Capital Structure and Updates on Liquidity, Cash Requirements and Share Repurchases - Quiver Quantitative
Cosmos Health projects $6M revenue from Oliv18 supplement launch - Investing.com India
COSM Looks 33.4% Undervalued on GF Value™ Despite Weak Fundamentals - GuruFocus
Cosmos Health projects $6M revenue from Oliv18 supplement launch By Investing.com - Investing.com Nigeria
Cosmos Health Projects Over $6M in Annual Revenue and $4.3M in Gross Profit from Oliv18™ Across the U.S. Cardiovascular Health and Antioxidant Categories - Barchart.com
Weekly Recap: Cosmos Health Q2 revenue gains and five‑year Innova Saudi deal - TradingView
Cosmos Health Inc. Projects Over $6 Million in Annual U.S. Revenue for Oliv18™ in 12 to 18 Months - Quiver Quantitative
Cosmos Health C-Sept PRO sales exceed $1.3 million at 72% margin - scanx.trade
9.43%
12.75%
자본화:
|
볼륨(24시간):